Monosaccaridi

3,4-O-Isopropylidene-b-D-arabinopyranose is a synthetic monosaccharide that is used in the synthesis of oligosaccharides and polysaccharides. It can be fluorinated, methylated, or glycosylated to produce a range of compounds with different properties. 3,4-O-Isopropylidene-b-D-arabinopyranose is not active against bacteria, but it does inhibit the growth of yeast cells. In addition to its use in biochemistry and as a nutritional supplement for animals and humans, 3,4-O-Isopropylidene-b-D-arabinopyranose can be used as an additive for plastics and other materials.

Benzyl 4-C-nitromethyl-b-D-arabinopyranoside is a synthetic glycosylation agent that is used in the synthesis of complex carbohydrates. It has been shown to react with methyl, fluorine, and saccharide groups. This product can be modified to include a wide range of saccharides, including monosaccharides, disaccharides, and polysaccharides. Benzyl 4-C-nitromethyl-b-D-arabinopyranoside is also available in custom synthesis and high purity.

Inositol nicotinate is a combination of two substances, inositol and nicotinate. It is used to reduce the risk of heart disease by lowering low-density lipoprotein-cholesterol (LDL) levels. Inositol nicotinate has been shown to increase the surface area of mitochondria, which may be due to its ability to inhibit the release of fatty acids from fat cells. Inositol nicotinate also increases magnesium levels in cells and induces mitochondrial functions. This drug has been tested in cell culture for its effects on skin cells and found that it can reduce the amount of x-linked adrenoleukodystrophy protein (XALD), a substance that accumulates in patients with X-linked adrenoleukodystrophy, an inherited disorder that causes progressive damage to the nervous system. The drugs also have been shown to have beneficial effects on cholesterol metabolism, reducing LDL cholesterol levels, as well as inhibiting platelet aggregation.

Losartan N1-glucuronide is a glucuronidated metabolite of losartan that is produced naturally in the human body. It is converted from losartan by the enzyme UDP-glucuronosyltransferase, which is found in humans and other animals. The rate of glucuronidation varies between individuals and is determined by genetic factors. Losartan N1-glucuronide has shown to be an effective inhibitor of angiotensin II, with an IC50 value of 1.4 μM. This inhibition can be reversed by dobutamine or recombinant human UGT2B7 enzyme, which are both competitive inhibitors of the enzyme UGT2B7. Magnetic resonance spectroscopy has been used to study the kinetic properties of this inhibitor and its effect on dobutamine-induced changes in cardiac function.

L-Ribose is a monosaccharide that is a constituent of ribonucleic acid, deoxyribonucleic acid and other compounds. It can be found in small quantities in most living organisms. L-Ribose has been modified to include fluorine atoms at the C2 position. The addition of fluorine atoms increases the stability of the molecule and its resistance to hydrolysis by esterases. L-Ribose has also been modified with methyl groups at the C3 position and glycosylation at the C4 position. This modification preserves the biological activity of L-Ribose and increases its water solubility. L-Ribose is used as a building block for custom synthesis, such as peptides or oligosaccharides.>>END>>

Sucralose is a non-nutritive artificial sweetener that has no calories and is used in place of sugar. It is made from sucrose by substituting three hydrogen-oxygen groups with three chlorine atoms. The deuterium isotope, D6, was used to prepare this compound for analysis because it only emits positrons that can be detected using a PET scanner. Sucralose-d6 was shown to have high resistance to degradation due to its strong bond between the carbon and oxygen atoms in the molecule. This property makes it more stable than other sugars and carbohydrates which are subject to hydrolysis by enzymes in wastewater treatment plants. Deionized water can be used as a sample preparation solvent for sucralose-d6 because it does not contain any ions that may react with this compound.

Didesmethylsibutamine D-glucuronide is a custom synthesis, complex carbohydrate, Oligosaccharide, CAS No. that is modified with saccharide and Methylation. It is synthesized with Carbohydrate and sugar to produce a high purity product. It also has the following modifications: Fluorination, Synthetic.

4-Methylphenyl 4,6-O-[bis(1,1-dimethylethyl)silylene]-1-thio-β-D-galactopyranoside is a synthetic sugar that is used in the glycosylation of proteins. It is synthesized from 4-methylphenol and 1,1'-dimethylethylsilylene in the presence of trichlorosilane, followed by silylation with trimethylchlorosilane. The fluorinated site can be modified to suit your needs by following a Click chemistry protocol. This product has CAS No. 1242144-05-3 and is available for custom synthesis upon request.

A 2-acetamido-3,6-di-O-benzoyl-2-deoxy-a-D-glucopyranoside is a custom synthesis of a complex carbohydrate that has been modified with methylation and glycosylation. It is an Oligosaccharide with Polysaccharide and Modification. The CAS number for this compound is 82827-77-8 and has a purity of 99%. This compound has been fluorinated and synthesized.

A sulfated galactose analogue

2,3-O-Cyclohexylidene-b-D-ribofuranose is a monosaccharide that is used in the synthesis of complex carbohydrates. This compound possesses a cyclic structure that contains an oxygen atom at the 2 position and a hydroxyl group at the 3 position. It has been modified by fluorination, methylation, glycosylation, and click chemistry. The chemical name for this compound is 2,3-O-Cyclohexylideneb-D-ribofuranose.

1,2,3,4-Tetra-O-acetyl-L-xylopyranose is a custom synthesis product. It is a sugar that is found in glycosaminoglycans and proteoglycans. This product can be customized through the modification of the sugar with fluorination, methylation, acetylation or other modifications. This product has a CAS number of 142130-89-0 and can be synthesized from sucrose using Click chemistry. The chemical name for this compound is 1,2,3,4-Tetra-O-[(trimethylsilyl)acetyl]-L-xylopyranose.

α-GalCer analog 8 is a high purity, custom synthesis, synthetic α-galactocerebrosidase enzyme that has been modified to include 8 fluorine atoms. The enzyme is glycosylated at the N-terminal and methylated at the C-terminal. The modification of this enzyme with an oligosaccharide and monosaccharide moiety improves its stability in vivo. α-GalCer analog 8 is used for the treatment of Gaucher's disease, which is caused by the accumulation of complex carbohydrates in the body. This condition can be managed using α-GalCer analog 8 because it hydrolyzes these complex carbohydrates into their monosaccharides.

Methylation is a process by which a methyl group is added to a substrate. This product is custom synthesized and has been modified with click chemistry. Methylation of saccharides, carbohydrates and other carbon-containing molecules is an important biochemical process in which the hydroxyl (-OH) group on the sugar or carbohydrate reacts with the -S-H bond on the methyl donor. This product also has fluorination and high purity.

Lipid X is a monosaccharide precursor of E. coli lipid A. It is an N-acyl-D-glucosamine 1-phosphate where the N-acyl group is (R)-3-hydroxytetradecanoyl and carrying an additional (R)-3-hydroxytetradecanoyl, and it is a component of the cell wall of Gram-negative bacteria. Due to its physiological functions and biological properties, Lipid X can be used to treat infectious diseases, autoimmune diseases, and HIV infection. It has also been shown to inhibit the production of inflammatory cytokines such as tumor necrosis factor alpha (TNF-α) and interleukin-1β (IL-1β). This effect is due to its ability to disrupt hydrogen bonds between lipids in the cell membrane. As a biosynthetic intermediate of Lipid A, it seems to play a role in bacterial virulence and can trigger an immune response in humans, and protect against endotoxins.

4,7,8,9-Tetra-O-acetyl-N-acetyl-D-neuraminic acid methyl ester is a modified form of sialic acid. This compound is a glycosylation product that has been modified with methyl groups and fluorine atoms. The fluorination of the molecule increases its stability and prevents it from being hydrolyzed by enzymes such as β-galactosidase. 4,7,8,9-Tetra-O-acetyl-N-acetyl-D-neuraminic acid methyl ester is often used in the synthesis of polysaccharides and oligosaccharides for medical purposes. This compound can be custom synthesized for research purposes or to meet special requirements.